Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation

Inflammatory myofibroblastic tumor (IMT), a rare sarcoma, is primarily treated via resection of the mass. However, in cases of recurrence or unresectable tumors, no standard care exists. While crizotinib, an anaplastic lymphoma kinase (ALK) inhibitor, is only approved for non-small-cell lung cancer...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Intern Med
Main Authors: Ogata, Misato, Hatachi, Yukimasa, Ogata, Takatsugu, Satake, Hironaga, Imai, Yukihiro, Yasui, Hisateru
Format: Artigo
Sprog:Inglês
Udgivet: The Japanese Society of Internal Medicine 2018
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478978/
https://ncbi.nlm.nih.gov/pubmed/30449794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1640-18
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker